Novogen Limited (KZIA)
(Delayed Data from NSDQ)
$0.20 USD
-0.01 (-4.61%)
Updated Jul 5, 2024 03:59 PM ET
After-Market: $0.20 0.00 (-0.30%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (82 out of 249)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | NA | 2.87 | 61.00 |
Year Ago Quarter Estimate | NA | -5.36 | 54.84 |
Next Quarter Estimate | NA | 7.43 | 63.00 |
Next Year Estimate | -0.33 | 29.71 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 56.58 | 15.40 | 15.67 |
Next Year | 0.00 | 9.60 | 9.31 |
Last 5 Years | NA | 3.70 | 8.10 |
Next 5 Years | NA | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.00 | 1.93 |
Price/Cash Flow (MRFY) | NA | 15.24 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -180.54% |
Return on Equity (TTM) | NA | -35.38% |
Debt to Equity (MRQ) | NA | 0.13 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.